Hochschulschrift
Alzheimer's disease - pathomechanisms and novel therapeutic strategies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
30 cm
- Extent
-
48 Seiten, 48 verschieden gezählte Seiten
- Language
-
Englisch
- Notes
-
Illustrationen, Diagramme
Enthält Sonderabdrucke
Technische Universität München, Habilitationsschrift, 2016
- Event
-
Veröffentlichung
- (where)
-
München
- (when)
-
2017
- Creator
-
Busche, Marc Aurel
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.03.2025, 12:28 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Busche, Marc Aurel
Time of origin
- 2017
Other Objects (12)
Alzheimer disease : therapeutic strategies
Initial Aβ seeds as therapeutic target for Alzheimer’s disease
Building multiscale computable model of Alzheimer’s disease and identification of novel mechanisms for new therapeutic interventions
Progressive neuroblastoma : innovation and novel therapeutic strategies
Measuring therapeutic efficacy in patients with Alzheimer’s disease: role of instruments
From pathological mechanisms underlying cardiovascular disease to novel therapeutic strategies in high-risk patients
Developing new models, unveiling disease mechanisms and identifying novel therapeutic strategies for cardiovascular diseases
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
Renal cell carcinoma in von Hippel-Lindau disease - from tumor genetics to novel therapeutic strategies
Alzheimer's disease
Promising Novel Therapeutic Strategies for Cisplatin Resistant Bladder Cancer
Sleep as a Novel Biomarker and a Promising Therapeutic Target for Cerebral Small Vessel Disease: A Review Focusing on Alzheimer’s Disease and the Blood-Brain Barrier
Alzheimer disease : therapeutic strategies
Initial Aβ seeds as therapeutic target for Alzheimer’s disease
Building multiscale computable model of Alzheimer’s disease and identification of novel mechanisms for new therapeutic interventions
Progressive neuroblastoma : innovation and novel therapeutic strategies
Measuring therapeutic efficacy in patients with Alzheimer’s disease: role of instruments
From pathological mechanisms underlying cardiovascular disease to novel therapeutic strategies in high-risk patients
Developing new models, unveiling disease mechanisms and identifying novel therapeutic strategies for cardiovascular diseases
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
Renal cell carcinoma in von Hippel-Lindau disease - from tumor genetics to novel therapeutic strategies
Alzheimer's disease
Promising Novel Therapeutic Strategies for Cisplatin Resistant Bladder Cancer
Sleep as a Novel Biomarker and a Promising Therapeutic Target for Cerebral Small Vessel Disease: A Review Focusing on Alzheimer’s Disease and the Blood-Brain Barrier
Alzheimer disease : therapeutic strategies
Initial Aβ seeds as therapeutic target for Alzheimer’s disease
Building multiscale computable model of Alzheimer’s disease and identification of novel mechanisms for new therapeutic interventions
Progressive neuroblastoma : innovation and novel therapeutic strategies
Measuring therapeutic efficacy in patients with Alzheimer’s disease: role of instruments
From pathological mechanisms underlying cardiovascular disease to novel therapeutic strategies in high-risk patients
Developing new models, unveiling disease mechanisms and identifying novel therapeutic strategies for cardiovascular diseases
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
Renal cell carcinoma in von Hippel-Lindau disease - from tumor genetics to novel therapeutic strategies
Alzheimer's disease
Promising Novel Therapeutic Strategies for Cisplatin Resistant Bladder Cancer